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Abstract
© 2016, Springer Science+Business Media New York.Data have been obtained on dynamics of
antibiotic susceptibility of Streptococcus pneumoniae isolates circulating in preschool children
suffering from respiratory pathologies, in the city of Kazan in the years 2009–2015. The high
activity  of  β-lactam antibiotics  (from 96 to  90.8  %,  depending on the period considered),
macrolides (from 83.7 to 93.4 %), and ciprofloxacin (78.9–73.5 %) for the causal treatment of
pneumococcal  infections.  No vancomycin-resistant  strains  of  pneumococci  were  registered.
Comparative analysis of 2009–2011 and 2015 showed a statistically significant increase of the
ratio of resistant strains to penicillin (3.5 %), amoxicillin/clavulanate (3.9 %), amoxicillin (5.3 %),
clarithromycin (3.6 %), clindamycin (2.9 %), ceftriaxone (5.2 %), and cefixime (2.3 %). According
to data on serotyping of isolates, serotypes of S. pneumoniae are covered by the 13-valent
conjugate vaccine currently used in children by the national calendar of preventive vaccination.
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